← Back to Search

Treatment for Tumors

N/A
Waitlist Available
Led By Julie R Gralow, MD
Research Sponsored by American Society of Clinical Oncology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights

Summary

The American Society of Clinical Oncology (ASCO) Survey on Coronavirus 2019 (COVID-19) in Oncology Registry (ASCO Registry) aims to help the cancer community learn more about the patterns of symptoms and severity of COVID-19 among patients with cancer, as well as how COVID-19 is impacting the delivery of cancer care and patient outcomes. The ASCO Registry collects both baseline and follow-up data on how the virus impacts cancer care and cancer patient outcomes during the COVID-19 pandemic.

Eligible Conditions
  • Tumors
  • Coronavirus Infection

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes to Cancer Treatments
Secondary outcome measures
All-cause mortality at 30 days
COVID-19 Symptoms
COVID-19 Treatments
+4 more

Find a Location

Who is running the clinical trial?

American Society of Clinical OncologyLead Sponsor
37 Previous Clinical Trials
141,149 Total Patients Enrolled
Suanna S Bruinooge, MPHStudy DirectorAmerican Society of Clinical Oncology
Julie R Gralow, MDPrincipal InvestigatorAmerican Society of Clinical Oncology
~1312 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top